Bullous pemphigoid (BP) is the most frequent subepidermal autoimmune blistering disease
and is caused by autoantibodies directed against two principal antigens of the …

Parkinson's disease is associated with a variety of dermatologic disorders and the study of
skin may provide insights into pathophysiological mechanisms underlying this common …

As we are aging, a number of cutaneous and extracutaneous disorders will be developed.
Although the pathogenesis of these aging-associated disorders is not clear yet …

Background Bullous pemphigoid (BP) and pemphigus vulgaris (PV) share similar
pathophysiology with venous thromboembolism (VTE) involving platelet activation, immune …

Background and objectives Bullous pemphigoid (BP) is associated with neuropsychiatric
disorders. Other comorbid diseases are discussed controversially. We evaluated the …

The incidence of autoimmune bullous disorders has increased over the years, especially in
elderly patients with multiple comorbidities, which has stimulated research into their …

Background Rituximab is a potential initial adjuvant therapy for bullous pemphigoid, yet
clinical experience is scarce. Objective We aimed to examine the clinical outcomes and …

Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of
the skin and mucous membranes. It is also associated with high mortality and poor …

Background Bullous pemphigoid (BP) is a rare autoimmune skin condition that causes large
fluid-filled blisters on the skin, especially in older adults. BP has been linked to various …

Although significant associations between bullous pemphigoid (BP) and certain
comorbidities, primarily subtypes of neurological disorders, have been reported in several …